PLx Pharma Irritated By Industry Self-Regulation Group’s Findings On Vazalore GI Comfort Claim

PLx disagrees with National Advertising Division’s recommendations following review on Bayer’s challenge of TV commercial and will appeal findings to National Advertising Review Board. NAD attorneys thank PLx’s “ voluntary participation” in SWIFT review but PLx makes clear it didn’t agree to a SWIFT process.

• Source: Alamy

PLx Pharma Inc. launched its Vazalore liquid-filled OTC aspirin formulated to improve absorption and reduce risk of stomach erosions and ulcers compared to immediate-release aspirin, after more than a decade of work. A competitor challenged advertising for Vazalore in an industry self-regulation forum within weeks of its launch.

PLx Pharma disagrees with the recommendations the BBB National Programs Inc

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Compliance

More from Policy & Regulation